Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Di Stilo

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|December 8, 1995
The furoxan system as a useful tool for balancing "hybrids" with mixed alpha 1-antagonist and NO-like vasodilator activitiesR Fruttero, D Boschi, A Di Stilo, et al.
Archiv Der Pharmazie|March 1, 1992
Potential histamine H2-receptor antagonists: synthesis and pharmacological activity of derivatives containing acylamino-furazan moietiesG Sorba, R Fruttero, A Di Stilo, et al.
Bioorganic & Medicinal Chemistry|September 8, 2000
Nicorandil analogues containing NO-donor furoxans and related furazansD Boschi, C Cena, A Di Stilo, et al.
Farmaco (Societa Chimica Italiana : 1989)|December 4, 1998
Pyrazole analogues of prazosinG Ermondi, D Boschi, A Di Stilo, et al.
Bioorganic & Medicinal Chemistry|February 1, 1995
The cyano-NNO-azoxy function in the design of an irreversible label for alpha 1 adrenoreceptorsG Sorba, A Di Stilo, C Medana, et al.
Archiv Der Pharmazie|October 1, 1994
Alpha 1-adrenoceptor blocking activity of some ring-open analogues of prazosinD Boschi, A Di Stilo, R Fruttero, et al.
Journal of Medicinal Chemistry|December 9, 1994
Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluationC Medana, G Ermondi, R Fruttero, et al.
Die Pharmazie|July 1, 1988
In vitro cytotoxic activity of aryl and heteroaryl-ONN-azoxycyanidesR Fruttero, R Calvino, A Di Stilo, et al.
Pharmaceutical Research|June 19, 2001
Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activitiesC Cena, S Visentin, A Di Stilo, et al.
Pharmaceutical Research|February 7, 1998
Studies on agents with mixed NO-dependent vasodilating and beta-blocking activitiesD Boschi, A Di Stilo, C Cena, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|December 8, 1995
The furoxan system as a useful tool for balancing "hybrids" with mixed alpha 1-antagonist and NO-like vasodilator activitiesR Fruttero, D Boschi, A Di Stilo, et al.
Archiv Der Pharmazie|March 1, 1992
Potential histamine H2-receptor antagonists: synthesis and pharmacological activity of derivatives containing acylamino-furazan moietiesG Sorba, R Fruttero, A Di Stilo, et al.
Bioorganic & Medicinal Chemistry|September 8, 2000
Nicorandil analogues containing NO-donor furoxans and related furazansD Boschi, C Cena, A Di Stilo, et al.
Farmaco (Societa Chimica Italiana : 1989)|December 4, 1998
Pyrazole analogues of prazosinG Ermondi, D Boschi, A Di Stilo, et al.
Bioorganic & Medicinal Chemistry|February 1, 1995
The cyano-NNO-azoxy function in the design of an irreversible label for alpha 1 adrenoreceptorsG Sorba, A Di Stilo, C Medana, et al.
Archiv Der Pharmazie|October 1, 1994
Alpha 1-adrenoceptor blocking activity of some ring-open analogues of prazosinD Boschi, A Di Stilo, R Fruttero, et al.
Journal of Medicinal Chemistry|December 9, 1994
Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluationC Medana, G Ermondi, R Fruttero, et al.
Die Pharmazie|July 1, 1988
In vitro cytotoxic activity of aryl and heteroaryl-ONN-azoxycyanidesR Fruttero, R Calvino, A Di Stilo, et al.
Pharmaceutical Research|June 19, 2001
Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activitiesC Cena, S Visentin, A Di Stilo, et al.
Pharmaceutical Research|February 7, 1998
Studies on agents with mixed NO-dependent vasodilating and beta-blocking activitiesD Boschi, A Di Stilo, C Cena, et al.
Pageof 3